Trump Administration Intervenes in Texas Planned Parenthood Lawsuit

The U.S. Justice Department has officially entered a multi-year legal battle in Texas, taking a direct role in a lawsuit that accuses Planned Parenthood of Medicaid fraud. The federal intervention, filed in court on Friday, marks a significant shift in the case, which was originally spearheaded by outgoing Republican Attorney General Ken Paxton. By stepping into the litigation, the Trump administration ensures the case continues even as state leadership transitions to newly elected Democrat Nathan Johnson.

The lawsuit centers on allegations that Planned Parenthood violated the federal False Claims Act by continuing to bill state Medicaid programs after Texas and Louisiana moved to terminate the organization's funding. The plaintiffs are seeking the return of funds collected during that period, along with substantial additional penalties. Estimates suggest the total judgment could reach $1.8 billion, a figure that Planned Parenthood representatives warn could force the organization to cease operations in the state.

Planned Parenthood has consistently maintained that its billing practices were lawful, arguing that it was entitled to collect payments while state termination decisions were temporarily blocked by court orders. The organization further contends that it cannot be held liable for the actions of its affiliates, as it was merely providing legal guidance. The case had been stalled for nearly three years until a unanimous ruling by the U.S. 5th Circuit Court of Appeals in August cleared the way for proceedings to resume.

This federal move arrives shortly after the recent midterm elections, where voters chose Nathan Johnson to replace Paxton. Johnson has previously expressed a desire to move away from using state resources for aggressive litigation against abortion providers, suggesting he might have reviewed or altered the state's approach to this case. By intervening, the federal government has effectively bypassed potential shifts in state-level strategy, ensuring the legal challenge remains active ahead of a proposed trial date in April 2027.